Evaluation of Gallium-68 prostate-specific membrane antigen, positron emission tomography/computed tomography (GA-68 PSMA PET/CT) in recurrent prostate cancer: a retrospective review of initial clinical experience at Tygerberg Hospital.
Humans
Male
Positron Emission Tomography Computed Tomography
/ methods
Retrospective Studies
Prostatic Neoplasms
/ diagnostic imaging
Gallium Radioisotopes
Aged
Neoplasm Recurrence, Local
Prostate-Specific Antigen
/ blood
Middle Aged
Gallium Isotopes
Neoplasm Grading
Aged, 80 and over
Edetic Acid
/ analogs & derivatives
Radiopharmaceuticals
/ administration & dosage
68Ga PSMA PET/CT
Prostate cancer
Tygerberg Hospital
Journal
The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926
Informations de publication
Date de publication:
2024
2024
Historique:
received:
03
11
2022
accepted:
02
05
2024
medline:
2
9
2024
pubmed:
2
9
2024
entrez:
2
9
2024
Statut:
epublish
Résumé
prostate cancer recurrence after definitive therapy for organ-confined disease often manifests as rising prostate-specific antigen (PSA) levels without clinically overt disease. a retrospective analysis of 177 a total of 177 there was an increase in the detection rate with an increase in the PSA. Gleason score was not a predictor of a positive
Identifiants
pubmed: 39220559
doi: 10.11604/pamj.2024.48.30.38084
pii: PAMJ-48-30
pmc: PMC11364939
doi:
Substances chimiques
Gallium Radioisotopes
0
Prostate-Specific Antigen
EC 3.4.21.77
Gallium Isotopes
0
gallium 68 PSMA-11
0
Edetic Acid
9G34HU7RV0
Radiopharmaceuticals
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
30Informations de copyright
Copyright: Bright Awadh Sangiwa et al.
Déclaration de conflit d'intérêts
The authors declare no competing interests.